Virtus ETF Advisers’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-4,733
Closed -$62.7K 438
2024
Q4
$62.7K Buy
4,733
+936
+25% +$22.7K 0.03% 437
2024
Q3
$127K Buy
3,797
+64
+2% +$2.19K 0.06% 343
2024
Q2
$93.5K Sell
3,733
-818
-18% -$19K 0.05% 341
2024
Q1
$102K Sell
4,551
-311
-6% -$7.36K 0.05% 360
2023
Q4
$104K Sell
4,862
-461
-9% -$7.95K 0.07% 344
2023
Q3
$95.6K Sell
5,323
-536
-9% -$10.2K 0.06% 339
2023
Q2
$119K Buy
5,859
+2,411
+70% +$48.9K 0.07% 330
2023
Q1
$75K Sell
3,448
-1,326
-28% -$32.2K 0.04% 396
2022
Q4
$148K Sell
4,774
-253
-5% -$7.14K 0.08% 348
2022
Q3
$128K Buy
5,027
+42
+0.8% +$985 0.05% 381
2022
Q2
$101K Buy
4,985
+36
+0.7% +$797 0.04% 427
2022
Q1
$122K Sell
4,949
-286
-5% -$8.66K 0.05% 263
2021
Q4
$182K Sell
5,235
-3,302
-39% -$105K 0.07% 243
2021
Q3
$232K Sell
8,537
-450
-5% -$11.4K 0.1% 228
2021
Q2
$233K Sell
8,987
-3,489
-28% -$83.6K 0.1% 235
2021
Q1
$269K Buy
12,476
+225
+2% +$5.68K 0.11% 266
2020
Q4
$263K Sell
12,251
-4,381
-26% -$106K 0.11% 292
2020
Q3
$245K Sell
16,632
-2,267
-12% -$40.9K 0.13% 271
2020
Q2
$422K Sell
18,899
-3,956
-17% -$72.3K 0.2% 179
2020
Q1
$323K Sell
22,855
-3,331
-13% -$50.5K 0.13% 218
2019
Q4
$426K Buy
26,186
+22,566
+623% +$534K 0.07% 238
2019
Q3
$127K Sell
3,620
-202
-5% -$9.61K 0.03% 281
2019
Q2
$216K Buy
+3,822
New +$275K 0.05% 283

Other funds holding ANAB

Virtus ETF Advisers's ANAB Position: Q1 2025 in Review

Virtus ETF Advisers sold out of AnaptysBio (ANAB) in Q1 2025, closing a stake of 4,733 shares — an estimated $62.7K sold.

Virtus ETF Advisers first reported a position in ANAB in Q2 2019 and held it in 23 quarters. The position peaked at $426K in Q4 2019. 153 funds tracked by Wall St. Rank hold ANAB as of Q1 2025.

  • Virtus ETF Advisers reported no remaining AnaptysBio position as of Q1 2025 after selling out during the quarter.
  • Virtus ETF Advisers sold 4,733 AnaptysBio shares in Q1 2025, an estimated $62.7K.
  • Virtus ETF Advisers first reported a position in AnaptysBio in Q2 2019 and held it in 23 quarters.
  • Virtus ETF Advisers's AnaptysBio position peaked at $426K in Q4 2019.
  • 153 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2025.

Based on Virtus ETF Advisers's 13F filing for Q1 2025, filed 14 May 2025.